Literature DB >> 2645690

Evaluation of the subacute nephrotoxicity of cyclohexane and other industrial solvents in the female Sprague-Dawley rat.

A M Bernard1, R de Russis, J C Normand, R R Lauwerys.   

Abstract

The subacute nephrotoxicity of more than 20 industrial solvents has been compared in female Sprague-Dawley rats. The animals were given 5 i.p. injections of the solvents per week for 2 weeks at doses ranging from 1/20 to 1/5 of the i.p. or oral LD50 and the urinary excretion of N-acetyl-beta-D-glucosaminidase, beta 2-microglobulin and albumin was determined. Under these experimental conditions, two solvents, cyclohexane and styrene, were found to cause some tubular injury as evidenced by a statistically significant increase of beta 2-microglobulinuria. At the same dose, styrene was more tubulotoxic than cyclohexane but the opposite was observed when the solvents were administered proportionally to their LD50. The increased beta 2-microglobulinuria caused by cyclohexane was both time- and dose-dependent. It was not accompanied by changes in the glomerular filtration rate and the renal plasma flow, but at the highest dose (1.5 g/kg) the renal concentrating ability was depressed. These renal tubular effects can most likely be ascribed to cyclohexanol, the main metabolite of cyclohexane. As cyclohexane is a widely used industrial solvent with a relatively high threshold limit value (TWA-TLV: 300 ppm) it might represent an underestimated risk for the renal function of exposed populations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645690     DOI: 10.1016/0378-4274(89)90018-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  1 in total

1.  Exposure monitoring and health effect studies of workers occupationally exposed to cyclohexane vapor.

Authors:  T Yasugi; T Kawai; K Mizunuma; R Kishi; I Harabuchi; J Yuasa; T Eguchi; R Sugimoto; K Seiji; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.